Comparison of clinical pharmacy specialists and primary care physicians in treatment of type 2 diabetes mellitus in rural Veterans Affairs facilities.
Results of a study to compare the impact of clinical pharmacy specialist (CPS) interventions with primary care physician (PCP) interventions in veterans with type 2 diabetes mellitus (T2D) in a rural setting are presented. A retrospective analysis was performed examining veterans diagnosed with T2D with a glycosylated hemoglobin (HbA1c) of ≥8% receiving treatment at a rural community-based outpatient clinic associated with the Memphis Veterans Affairs Medical Center. Propensity score matching was used to create a 1:1 cohort of patients managed by physicians or clinical pharmacy specialists. Patients were evaluated as their own control and as compared cohorts. The primary outcome was the difference in HbA1c. Secondary outcomes included changes in total cholesterol, low-density lipoprotein cholesterol, triglycerides, and body mass index. Data were collected from 124 patients (n = 62 CPS patients, n = 62 PCP patients). Baseline HbA1c in the CPS and PCP groups were 10.2% ± 1.9% and 9.6% ± 1.6%, respectively. Postintervention HbA1c in the CPS cohort was 7.5% ± 1.1% (range, 6-11.7%), indicating an absolute reduction of 2.7% (p < 0.001). Postintervention HbA1c in the PCP cohort was 8.5% ± 1.5% (range, 5.4-12.6%), resulting in an absolute reduction of 1.1% (p < 0.001). The CPS intervention resulted in a greater mean HbA1c absolute reduction of 1.6 percentage points compared to physician intervention (p < 0.001). Compared with physician intervention, clinical pharmacy intervention in the treatment of T2D led to a greater mean HbA1c reduction in patients receiving care through VA facilities in rural settings.